Filing Details
- Accession Number:
- 0001209191-18-055586
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-18 17:36:30
- Reporting Period:
- 2018-10-16
- Accepted Time:
- 2018-10-18 17:36:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1253689 | Glycomimetics Inc | GLYC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1589713 | L. John Magnani | C/O Glycomimetics, Inc. 9708 Medical Center Drive Rockville MD 20850 | Svp Of Research, Cso | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2018-10-16 | 14,200 | $14.01 | 86,593 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-10-17 | 7,273 | $14.00 | 79,320 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2018-10-18 | 3,527 | $14.02 | 75,793 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 4,845 | Indirect | By GlycoTech Corporation |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b-5 trading plan adopted by the reporting person on September 21, 2018.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to$14.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.00 to$14.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities andExchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth herein.
- These shares are held by GlycoTech Corporation, of which the reporting person is the sole stockholder.
Billionaire Hedge Funds
